Winner Medical Co., Ltd.
Shenzhen Stock ExchangeTotal Valuation
Winner Medical Co., Ltd. carries a market capitalization of 16.78B, placing it among publicly traded companies globally. Its enterprise value stands at 23.32B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 16.78B |
| Enterprise Value | 23.32B |
Share Statistics
Winner Medical Co., Ltd. currently has 582.33M shares outstanding.
| Shares Outstanding | 582.33M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Valuation Ratios
Winner Medical Co., Ltd. trades at a trailing price-to-earnings ratio of 29.58. The price-to-sales ratio is 2.32, and the price-to-book ratio stands at 3.08.
| PE Ratio | 29.58 |
| PS Ratio | 2.32 |
| PB Ratio | 3.08 |
| P/TBV Ratio | 2.38 |
| P/FCF Ratio | 30.90 |
| P/OCF Ratio | N/A |
Enterprise Valuation
On an enterprise value basis, Winner Medical Co., Ltd. trades at an EV/EBITDA multiple of 19.63 and an EV/FCF ratio of 28.50. The EV/Sales ratio of 2.28 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 19.63 provides insight into valuation relative to core operating earnings.
| EV / Sales | 2.28 |
| EV / EBITDA | 19.63 |
| EV / EBIT | 19.63 |
| EV / FCF | 28.50 |
Financial Position
Winner Medical Co., Ltd. maintains a current ratio of 1.68, meaning it holds 1.7x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 20.12, indicating elevated leverage, while an interest coverage ratio of 18.84 demonstrates strong ability to service its debt obligations.
| Current Ratio | 1.68 |
| Quick Ratio | 0.81 |
| Debt / Equity | 20.12 |
| Debt / EBITDA | 2.08 |
| Interest Coverage | 18.84 |
Financial Efficiency
Winner Medical Co., Ltd. posts a return on equity of 10.71 and a return on invested capital of 6.52.
| Return on Equity (ROE) | 10.71 |
| Return on Assets (ROA) | 4.64 |
| Return on Invested Capital (ROIC) | 6.52 |
| Return on Capital Employed (ROCE) | 7.77 |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 3.18 |
Taxes
Over the trailing twelve months, Winner Medical Co., Ltd. has paid 227.93M in income taxes, reflecting an effective tax rate of 21.09.
| Income Tax | 227.93M |
| Effective Tax Rate | 21.09 |
Stock Price Statistics
Winner Medical Co., Ltd.'s stock has declined approximately -27.75408% over the past 52 weeks. The 50-day moving average sits at 29.47, while the 200-day moving average is 35.12.
| Beta (5Y) | N/A |
| 52-Week Price Change | -27.75408% |
| 50-Day Moving Average | 29.47 |
| 200-Day Moving Average | 35.12 |
| Average Volume (20 Days) | N/A |
Income Statement
Over the trailing twelve months, Winner Medical Co., Ltd. generated 10.24B in revenue and converted that into 803.23M in net income, yielding earnings per share of 1.48. EBITDA reached 1.19B, while operating income came in at 1.19B.
| Revenue | 10.24B |
| Gross Profit | 4.84B |
| Operating Income | 1.19B |
| Pretax Income | 1.08B |
| Net Income | 803.23M |
| EBITDA | 1.19B |
| EBIT | 1.19B |
| Earnings Per Share (EPS) | 1.48 |
Balance Sheet
Winner Medical Co., Ltd. holds 3.66B in cash and equivalents against 2.47B in total debt, resulting in a net debt position of 318.44M. Total book value stands at 7.71B, with working capital of 3.10B providing operational flexibility.
| Cash & Cash Equivalents | 3.66B |
| Total Debt | 2.47B |
| Net Debt | 318.44M |
| Equity (Book Value) | 7.71B |
| Book Value Per Share | 13.34 |
| Working Capital | 3.10B |
Cash Flow
After subtracting -768.77M in capital expenditures, free cash flow totaled -768.77M - equivalent to -1.33 per share.
| Operating Cash Flow | N/A |
| Capital Expenditures | -768.77M |
| Free Cash Flow | -768.77M |
| FCF Per Share | -1.33 |
Margins
Winner Medical Co., Ltd. operates with a gross margin of 47.29, reflecting its pricing power and cost economics. The operating margin of 11.60 and net profit margin of 7.84 provide insight into operational efficiency.
| Gross Margin | 47.29 |
| Operating Margin | 11.60 |
| Pretax Margin | 10.55 |
| Profit Margin | 7.84 |
| EBITDA Margin | 11.60 |
Dividends & Yields
The company's payout ratio of 59.89 indicates the proportion of earnings distributed to shareholders.
| Dividend Per Share | 0.93 |
| Dividend Yield | N/A |
| Payout Ratio | 59.89 |
| Shareholder Yield | 2.77 |
| FCF Yield | 3.24 |
Stock Splits
Winner Medical Co., Ltd.'s most recent stock split took place on June 2, 2023 with a 5:7 split ratio.
| Last Split Date | 6/2/2023 |
| Split Ratio | 5:7 |
Scores
Winner Medical Co., Ltd. posts an Altman Z-Score of 4.26, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 4.26 |